CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

upb-101

mAbexperimental

Clinical trial activity

6 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Jun 27, 2022 (NCT05448651)

Timeline

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06981078Phase 2Jul 2, 2025Upstream Bio Inc.
NCT06966479Phase 2May 21, 2025Upstream Bio Inc.
NCT06196879Phase 2Feb 27, 2024Upstream Bio Inc.
NCT06164704Phase 2Dec 18, 2023Upstream Bio Inc.
NCT05653479Phase 1Dec 5, 2022Upstream Bio Inc.
NCT05448651Phase 1Jun 27, 2022Upstream Bio Inc.
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Upstream Bio Inc.For profit6622022
1 organizations
Page 1 / 1